Evidence map›Paper›PMID 40109657›Full record

ArticleJournal of inflammation research2025

Identification of

Hengrong Qian, Sheng Gao, Ting Zhang, Yuanyuan Xie, Siyan Chen, Yanggang Hong, Xinlei Wu, Zhouhang Xing, Lingjie Kong, Jintao Mo and 5 more

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Exosomes as immunomodulators in autoimmune inflammation: implications for primary Sjögren's disease.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hengrong Qian *School of the 2nd Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Sheng Gao *Laboratory Animal Center, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Ting Zhang *Department of Rheumatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Yuanyuan Xie *School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Siyan Chen *School of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Yanggang Hong *School of the 2nd Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.ORCID 0009-0004-4507-0093
Xinlei WuSchool of the 2nd Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Zhouhang XingSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Lingjie KongSchool of the 2nd Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Jintao MoSchool of the 1st Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Yiming LinSchool of the 1st Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Anzhe ZhengSchool of the 2nd Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Wenqian WangDepartment of Plastic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.ORCID 0000-0003-2925-4306
Liangxing WangKey Laboratory of Heart and Lung, Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
Chunyan HuaSchool of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.ORCID 0000-0001-7957-6106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Systemic lupus erythematosus (SLE) is characterized by aberrant immune activation and disrupted iron metabolism, yet the molecular mediators that govern both processes remain unclear. This study aims to identify pivotal genes that modulate immune responses and iron metabolism, and to delineate their contributions to SLE pathogenesis. Methods: Differentially expressed genes related to iron metabolism (IM-DEGs) were identified using datasets (GSE72326, GSE110169, GSE126307, and GSE50772) from the GEO database and the MSigDB. Functional enrichment analyses were performed on the iron metabolism related genes (IM-Genes). A weighted gene co-expression network analysis was constructed to identify hub genes, which were further refined as potential biomarkers using the least absolute shrinkage and selection operator method. The predictive value of these biomarkers was validated using receiver operating characteristic (ROC) curves and the nomogram. CIBERSORT was employed to evaluate immune cell infiltration in SLE. Additionally, the expression and function of Results: Bioinformatics analyses identified 4 potential biomarkers: Conclusion: Our findings suggest that

Indexed as

biomarkerdendritic cellinflammationiron metabolismRSAD2systemic lupus erythematosus

Identifiers

PMID40109657
PMCPMC11920641

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.